LeonaBio, Inc. (LONA) Live Share Price, Invest From India

LeonaBio, Inc. Stock Performance

as on June 3, 2026 at 6:59 am IST

Day's Low
Day's High
$9.00
Day's Price Range
$10.04
$9.11
1.21%
Downside
10.21%
Upside
52 Week's Low
52 Week's High
52-Week Price Range
$9.11
100.00%
Downside
-100.00%
Upside

LeonaBio, Inc. share price movements today

Previous Close: $9.29
Open: $10.04
Volume: 140.1K
Day's Low - High: $9.00 - $10.04

LeonaBio, Inc. Historical Returns

1 Month Return: + 5.33 %
3 Month Return: + 62.41 %
1 Year Return: 0 %
3 Year Return: 0 %
5 Year Return: 0 %

LeonaBio, Inc. Stock Fundamentals & Key Indicators

Check LeonaBio, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$89.6M

EPS (TTM)

-3.12

Dividend Yield

0.00%

PE Ratio (TTM)

PEG Ratio

Return On Equity TTM

-298.76%

LeonaBio, Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of LeonaBio, Inc. with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
LeonaBio, Inc.	NA	$89.6M	NA	NA	0.00%	NA
Revolution Medicines Inc	BUY	$33.5B	434.2%	NA	0.00%	NA
Alnylam Pharmaceuticals Inc	BUY	$40.3B	106.95%	75.68	12.55%	NA
Vertex Pharmaceuticals Inc	BUY	$113.6B	108.38%	26.53	35.51%	NA
Regeneron Pharmaceuticals Inc	BUY	$64.5B	18.86%	15.02	29.65%	0.58%

Indian Investors' Interest in LeonaBio, Inc. Stock

Search interest for LeonaBio, Inc. Stock has decreased by -48% in the last 30 days, reflecting a downward trend in search activity.

Time period: May 4, 2026 to June 3, 2026

Change:-48% versus previous 30 day period

LeonaBio, Inc. Quarterly Profit & Loss

All numbers in Millions USD

	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Total Revenue	-	-	-	-	-	-	-
Gross Profit	-	-	0	0	0	-68	-
Operating Income	-29	-15	-9	-7	-6	-78	-17
EBITDA	-25	-15	-8	-6	-6	-78	-17
Interest Expense	-	-	-	-	-	-	-
Depreciation	0	0	0	0	0	0	0
Income Before Tax	-28	-15	-9	-6	-6	-82	-32
Income Tax Expense	-	-	-	-	-	-	-
Net Income	-28	-15	-9	-6	-6	-82	-32
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

LeonaBio, Inc. Annual Profit & Loss

All numbers in Millions USD

	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	-	-	-	-	-
Gross Profit	0	-	-	-	-68
Operating Income	-64	-104	-125	-100	-102
EBITDA	-54	-88	-125	-95	-102
Interest Expense	0	24	-	-	-
Depreciation	0	0	0	0	0
Income Before Tax	-54	-95	-117	-96	-105
Income Tax Expense	-	-	-	-	-
Net Income	-54	-95	-117	-96	-105
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%

LeonaBio, Inc. Quarterly Cash Flow

All numbers in Millions USD

	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Net Income	-26	-26	-28	-15	-9	-6	-6	-82	-32
Operating Cash Flow	-25	-22	-23	-26	-14	-6	-4	-19	-20
Investing Cash Flow	13	26	18	-2	-7	0	5	-14	-15
Financing Cash Flow	-	0	0	0	-	0	-	82	-
Change in Cash	-12	4	-4	-28	-22	-6	0	48	-36

LeonaBio, Inc. Annual Cash Flow

All numbers in Millions USD

	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Net Income	-5	-19	-54	-95	-117	-96	-105
Operating Cash Flow	-3	-24	-43	-72	-100	-97	-45
Investing Cash Flow	1	-210	-4	57	95	54	-15
Financing Cash Flow	0	292	97	0	0	0	82
Change in Cash	-1	58	49	-14	-5	-42	20

Global Institutional Holdings in LeonaBio, Inc.

Funds	Holdings
Propel Bio Management LLC	1.6%
Simplify Asset Management Inc.	1.6%
Northern Trust Corp	0.15%
Perceptive Advisors LLC	19.92%
Vanguard Group Inc	1.65%

See all

Insights on LeonaBio, Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Price Rise
In the last 3 months, LONA stock has moved up by 62.4%
NO EFFECT
Against Peers
In the last 1 year, Revolution Medicines, Inc. Common Stock has given 302.7% return, outperforming this stock by 76.8%
NO EFFECT
Against Peers
In the last 3 years, Revolution Medicines, Inc. Common Stock has given 540.1% return, outperforming this stock by 609.3%

About LeonaBio, Inc.

LeonaBio, Inc., clinical-stage biopharmaceutical company, engages in the development of novel therapeutics for high unmet medical needs, including treatment-resistant metastatic breast cancer and amyotrophic lateral sclerosis. The company's lead products include lasofoxifene and ATH-1105, a novel small molecule therapies with the potential to address devastating diseases where current treatment options are limited or ineffective. Its product pipeline includes ATH-1105 for the treatment of amyotrophic lateral sclerosis, which is in phase 1 clinical trial; ATH-1020 for the treatment of diabetic neuropathy, which is in phase 1 clinical trial; and ATH-1017 for the treatment of Alzheimer's disease and Parkinson's disease, which is in phase 2 clinical trial, as well as early compounds which is in preclinical phase. The company was formerly known as Athira Pharma, Inc. and changed its name to LeonaBio, Inc. in January 2026. LeonaBio, Inc. was incorporated in 2011 and is headquartered in Bothell, Washington.

Organisation	LeonaBio, Inc.
Headquarters	18706 North Creek Parkway, Bothell, WA, United States, 98011
Industry	Biotechnology
CEO	Dr. Mark J. Litton M.B.A., Ph.D.
E-voting on shares	Click here to vote

Key Management of LeonaBio, Inc.

Name	Title
Mr. Mark F. Kubik M.B.A.	Chief Business Officer
Dr. Mark J. Litton M.B.A., Ph.D.	President, CEO & Director
Mr. Mark F. Worthington J.D.	General Counsel, Chief Compliance Officer & Corporate Secretary
Dr. Javier San Martin M.D.	Chief Medical Officer
Mr. Robert Renninger	Chief Financial Officer
Dr. Kevin Church Ph.D.	Chief Scientific Officer
Ms. Julie Rathbun	Head of Investor Relations

FAQs

What is LeonaBio, Inc. share price today?

LeonaBio, Inc. share price today is $9.11 as on June 3, 2026 at 1:29 am IST at the close of the market. LeonaBio, Inc. share today touched a day high of $10.04 and a low of $9.

What is the 52 week high and 52 week low for LeonaBio, Inc. share?

LeonaBio, Inc. share touched a 52 week high of $0 on January 1, 1970 and a 52 week low of $0 on January 1, 1970. LeonaBio, Inc. stock price today i.e. June 3, 2026 at 1:29 am IST is closed at $9.11,which is -Infinity% down from its 52 week high and Infinity% up from its 52 week low.

What is LeonaBio, Inc.'s market capitalisation today?

LeonaBio, Inc. market capitalisation is $0.00T as on June 3, 2026 at 1:29 am IST.

How to invest in LeonaBio, Inc. Stock (LONA) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for LeonaBio, Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in LeonaBio, Inc. Shares that will get you 0.1647 shares as per LeonaBio, Inc. share price of $9.11 per share as on June 3, 2026 at 1:29 am IST.

What is the minimum amount required to buy LeonaBio, Inc. Stock (LONA) from India?

Indian investors can start investing in LeonaBio, Inc. (LONA) shares with as little as ₹95.265 or $1 (as of June 3, 2026 at 6:00 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹952.65 in LeonaBio, Inc. stock (as per the Rupee-Dollar exchange rate as on June 3, 2026 at 6:00 am IST). Based on LeonaBio, Inc. share’s latest price of $9.11 as on June 3, 2026 at 1:29 am IST, you will get 1.0977 shares of LeonaBio, Inc.. Learn more about fractional shares .